drug failure fibromyalgia

Tomnya appeared to have everything going for it until it tanked in a Phase 3 fibromyalgia trial

Tomnya had everything going for it; a novel approach to pain and good Phase II trial results, but Tonix’s reformulation of Flexeril that was expected to help with both sleep and pain tanked in its critical Phase III trial.

Check out what happened with it, and get an update on four other drugs that may get approved for FM in the next couple of years in
Print Friendly, PDF & Email

Don't Miss Another Blog!

Like this blog?

Make sure you don’t miss another  one by registering for our free ME/CFS and Fibromyalgia blogs here..

Pin It on Pinterest

Share This